PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Noronex Limited (NRX.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU0000116469

Sector

Basic Materials

Industry

Copper

Highlights

Market Cap

A$7.99M

EPS (TTM)

-A$0.01

EBITDA (TTM)

-A$927.17K

Year Range

A$0.01 - A$0.02

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Noronex Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2025February
23.05%
15.54%
NRX.AX (Noronex Limited)
Benchmark (^GSPC)

Returns By Period

Noronex Limited had a return of 45.45% year-to-date (YTD) and 23.08% in the last 12 months.


NRX.AX

YTD

45.45%

1M

33.33%

6M

23.08%

1Y

23.08%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

3.96%

1M

2.77%

6M

10.09%

1Y

21.57%

5Y*

12.62%

10Y*

11.30%

*Annualized

Monthly Returns

The table below presents the monthly returns of NRX.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202536.36%45.45%
20240.00%-8.33%36.36%0.00%-6.67%-21.43%27.27%0.00%14.29%-12.50%-21.43%-0.00%-8.33%
2023-13.95%-9.46%-32.09%-10.99%-0.00%-11.73%4.90%0.00%-6.67%-28.57%10.00%9.09%-65.12%
20221.31%-1.29%-18.72%-3.06%-20.60%-24.06%-2.48%24.29%-24.09%-8.38%-15.69%33.33%-54.97%
20218.64%24.04%-22.55%12.47%0.00%11.09%6.70%-12.49%-3.59%0.00%-22.25%-23.83%-30.48%
20203.59%-20.71%-17.86%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of NRX.AX is 58, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of NRX.AX is 5858
Overall Rank
The Sharpe Ratio Rank of NRX.AX is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of NRX.AX is 6262
Sortino Ratio Rank
The Omega Ratio Rank of NRX.AX is 6161
Omega Ratio Rank
The Calmar Ratio Rank of NRX.AX is 5757
Calmar Ratio Rank
The Martin Ratio Rank of NRX.AX is 5757
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Noronex Limited (NRX.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for NRX.AX, currently valued at 0.22, compared to the broader market-2.000.002.004.000.221.83
The chart of Sortino ratio for NRX.AX, currently valued at 1.17, compared to the broader market-6.00-4.00-2.000.002.004.006.001.172.47
The chart of Omega ratio for NRX.AX, currently valued at 1.16, compared to the broader market0.501.001.502.001.161.33
The chart of Calmar ratio for NRX.AX, currently valued at 0.25, compared to the broader market0.002.004.006.000.252.76
The chart of Martin ratio for NRX.AX, currently valued at 0.95, compared to the broader market-10.000.0010.0020.0030.000.9511.27
NRX.AX
^GSPC

The current Noronex Limited Sharpe ratio is 0.22. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Noronex Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.22
2.07
NRX.AX (Noronex Limited)
Benchmark (^GSPC)

Dividends

Dividend History


Noronex Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-90.43%
-1.59%
NRX.AX (Noronex Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Noronex Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Noronex Limited was 94.62%, occurring on Nov 9, 2023. The portfolio has not yet recovered.

The current Noronex Limited drawdown is 90.43%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.62%Jun 9, 2021528Nov 9, 2023
-35.28%Feb 24, 202122Mar 29, 202147Jun 4, 202169
-27.63%Dec 1, 202016Dec 22, 202010Jan 8, 202126
-24.29%Jan 11, 202114Jan 29, 202116Feb 22, 202130
-17.86%Nov 19, 20201Nov 19, 20206Nov 27, 20207

Volatility

Volatility Chart

The current Noronex Limited volatility is 32.12%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
32.12%
3.33%
NRX.AX (Noronex Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Noronex Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Noronex Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab